Navigation Links
Tekturna, First New Type of High Blood Pressure Medicine in a,Decade, Provides Additional Blood Pressure Reduction When Used With,Diovan

forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, gastrointestinal and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG , a world leader in offering medicines to protect health, treat disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. Novartis is the only company with leadership positions in both patented and generic pharmaceuticals. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

    Media contacts

    Maura Bergen

    Novartis Pharmaceuticals Corporation

    862-778-4146 (direct)

    917-334-0903 (mobile) (onsite in New Orleans)

    


    Heather Rose

    Novartis Pharmaceuticals Corporation

    862-778-1414 (direct)

    917-859-4086 (mobile)





Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model

Post Your Comments:
(Date:11/6/2009)...rstCall/ -- NuVasive, Inc. (Nasdaq: NUVA ), a med... for minimally disruptive surgical treatments for ...ael J. Lambert as Executive Vice President and Chi... The Company also announced several other Executiv...an excellent complement to the NuVasive family," s...
(Date:11/6/2009)...wire/ -- Philips Respironics applauds the efforts ...(CDC) to raise awareness about an important public...CDC,s release of the first-ever government study t...ess is a milestone in quantifying the size and sco... industry leader and sleep therapy manufacturer, P...
(Date:11/6/2009)...stCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq:...ovember 10, 2009 at 8:30 a.m. EST to discuss the t...utlook for the remainder of 2009. Ron Bentsur, Ch...e call. Keryx will announce its financial results...rior to the call. ,, In order to participate in...
Breaking Medicine Technology:NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Business Health Care Leaders Call on Texas Employers to Cover Smoking Cessation Benefits for an Additional 100 000 People by 2010 50074 1Business Health Care Leaders Call on Texas Employers to Cover Smoking Cessation Benefits for an Additional 100 000 People by 2010 50074 2Business Health Care Leaders Call on Texas Employers to Cover Smoking Cessation Benefits for an Additional 100 000 People by 2010 50074 3Virus filters for medical diagnosis 50068 1Virus filters for medical diagnosis 50068 2New research shows dinosaurs may have been smaller than we thought 9003 1New research shows dinosaurs may have been smaller than we thought 9003 2
...chers, Study Shows Promising Treatment for People ...e of Esophageal Cancer, WILMINGTON, MASSACHUSETTS-...ls, Inc. (NASDAQ GM:DUSA) announced that the U.S. ...han Drug Designation,for Levulan(R) (aminolevulini...atment of esophageal dysplasia. This disease occur...
...rin Contaminated with Diethylene Glycol,(DEG) Rema...CKVILLE, Md., May 4, 2007-The U.S. Food and Drug,A...facturers,suppliers, drug repackers, and health p...ally vigilant in assuring that glycerin, a,sweeten...ter and,prescription drug products, is not contami...
Other Medicine Technology:DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan,PDT to Treat Esophage al Dysplasia 2DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan,PDT to Treat Esophage al Dysplasia 3DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan,PDT to Treat Esophage al Dysplasia 4FDA Advises Manufacturers to Test Glycerin for Possible,Contamination 2
(Date:11/7/2009)...HOUSTON, Nov. 7 Calling this a "de...n (AMA), the AMA President J. James Rohack, M.D., ...ians from all state and medical specialty societie...aking meeting, where health system reform will top.../cgi-bin/prnh/20081209/AMALOGO ) ,, "Over the...
(Date:11/7/2009)... Brown: "Faithful Catholics have a responsibility...negotiate the status quo." ,, WASHINGTON, Nov...ague president Judie Brown released the following ...will support Speaker Nancy Pelosi,s Affordable Hea...amendment preserving the status quo for abortion i...
(Date:11/7/2009)...GTON, Nov. 7 Americans United for Life Action end...tupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-S...al money from going to abortion in health care ref...nt and CEO Dr. Charmaine Yoest said, "Americans Un...Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith A...
(Date:11/7/2009)... fight back to stem a growing problem across the U...-- Nearly half of students at four-year colleges d... binge drinking -- downing five or more alcoholic ...entifying alcohol as a drug," said Jenny Hwang, as...eling center at Stony Brook University on Long Isl...
(Date:11/7/2009)... Forget ‘sweatox’ or...he UK is the usage of the anti-ageing jab ‘B...n injected into the décolletage, can reduce...he chest area around the breasts, leaving smoother... (PRWEB) November 7, 2009 -- Transform, the UK&rsq...
Breaking Medicine News(10 mins):Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:UK Boobs Get a Boost with 'Breastox' 2
...over Hidden Defects in Maple Bats Before Disaster ...hes, CLEVELAND, June 23 The world,s first baseba...y-operated CT scanner -- able to,detect hidden fla... 27, 2008, at the Society For American Baseball,Re...
...ti-fouling medical device,coatings developed by Ne...rds recognizing innovation in medical technology. ... and the Lawson Health Research Institute,tested u... coatings, which cannot protect,against resistant ...
...t with their babies in the first year of life is s...oth a mother,s parenting style and an infant,s tem...later childhood, according to Benjamin Lahey and h...gy . , The researchers looked at whether an infan...
...wire-FirstCall/ - CRH Medical Corporation,(CRM:TSX...r Colorectal,Health in San Diego CA. This Center i...one of many markets that CRH has targeted for expa...the National Institute of Health, the prevalence r...
...rdinating Office for Terrorism Preparedness and ...OOK, Md., June 23 Lockheed Martin (NYSE: LMT ) w... Prevention (CDC) to provide,Information Technolog...r and three option years, with an estimated,progra...
...3 The American Society of,Transplantation (AST) r...dge Distinguished Achievement Award, to Richard N.... Toronto, Canada. The award recognizes a,senior in... and far-reaching., Dr. Fine served the AST as pr...
Other Medicine News:Health News:Bat Scan to the Rescue: New Clubhouse CT Scanner Helps Eliminate Exploding Bats 2Health News:Bat Scan to the Rescue: New Clubhouse CT Scanner Helps Eliminate Exploding Bats 3Health News:Nerites Technology Wins Scientific Accolades 2Health News:Mothers' influence is decisive in tots' first year 2Health News:CRH Medical Corporation opens Center in San Diego California 2Health News:Lockheed Martin Wins $24 Million IT Contract With CDC 2Health News:AST Awards Richard N. Fine, M.D. 2008 Ernest Hodge Distinguished Achievement Award 2
Suturing Forceps (Bishop Harmon)
Adson Forceps
...es with polished metal rims in an elegant carrying...20.00 Diopters (0.25D increments) , ,70 Spheri...ncrements), ,34 Cylindrical Concave Lenses: 0....lindrical Convex Lenses: 0.12 to 6.00 Diopters (0....
Ultramatic RX Master PHOROPTOR Refracting Instrument - Plus Cylinder White
Medicine Products: